speb/financial-data huggingface dataset:
BAYERCROP.NS balance_sheet (annual, 2024-03-31) — Other Intangible Assets: 1254000000.00
BAYERCROP.NS balance_sheet (annual, 2024-03-31) — Other Inventories: 655000000.00
BAYERCROP.NS cash_flow (annual, 2024-03-31) — Other Non Cash Items: -376000000.00
BAYERCROP.NS balance_sheet (annual, 2024-03-31) — Other Non Current Assets: 313000000.00
BAYERCROP.NS income_statement (annual, 2024-03-31) — Other Non Operating Income Expenses: 148000000.00
BAYERCROP.NS income_statement (annual, 2024-03-31) — Other Operating Expenses: 2380000000.00
BAYERCROP.NS balance_sheet (annual, 2024-03-31) — Other Payable: 4969000000.00
BAYERCROP.NS balance_sheet (annual, 2024-03-31) — Other Properties: 470000000.00
BAYERCROP.NS balance_sheet (annual, 2024-03-31) — Other Receivables: 60000000.00
BAYERCROP.NS balance_sheet (annual, 2024-03-31) — Other Short Term Investments: 539000000.00
BAYERCROP.NS income_statement (annual, 2024-03-31) — Other Special Charges: 24000000.00
BAYERCROP.NS income_statement (annual, 2024-03-31) — Otherunder Preferred Stock Dividend: 0.00
BAYERCROP.NS balance_sheet (annual, 2024-03-31) — Payables: 11085000000.00
BAYERCROP.NS balance_sheet (annual, 2024-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 518000000.00
BAYERCROP.NS balance_sheet (annual, 2024-03-31) — Prepaid Assets: 1391000000.00
BAYERCROP.NS income_statement (annual, 2024-03-31) — Pretax Income: 9414000000.00
BAYERCROP.NS balance_sheet (annual, 2024-03-31) — Properties: 0.00
BAYERCROP.NS cash_flow (annual, 2024-03-31) — Provisionand Write Offof Assets: 70000000.00
BAYERCROP.NS cash_flow (annual, 2024-03-31) — Purchase Of PPE: -457000000.00
BAYERCROP.NS balance_sheet (annual, 2024-03-31) — Raw Materials: 7277000000.00
BAYERCROP.NS income_statement (annual, 2024-03-31) — Reconciled Cost Of Revenue: 29431000000.00
BAYERCROP.NS income_statement (annual, 2024-03-31) — Reconciled Depreciation: 740000000.00
BAYERCROP.NS income_statement (annual, 2024-03-31) — Rent And Landing Fees: 136000000.00
BAYERCROP.NS income_statement (annual, 2024-03-31) — Rent Expense Supplemental: 136000000.00
BAYERCROP.NS balance_sheet (annual, 2024-03-31) — Restricted Cash: 72000000.00
BAYERCROP.NS balance_sheet (annual, 2024-03-31) — Retained Earnings: 23071000000.00
BAYERCROP.NS cash_flow (annual, 2024-03-31) — Sale Of Business: 0.00
BAYERCROP.NS cash_flow (annual, 2024-03-31) — Sale Of Investment: 17000000.00
BAYERCROP.NS cash_flow (annual, 2024-03-31) — Sale Of PPE: 63000000.00
BAYERCROP.NS income_statement (annual, 2024-03-31) — Selling And Marketing Expense: 3287000000.00
BAYERCROP.NS income_statement (annual, 2024-03-31) — Selling General And Administration: 4755000000.00
BAYERCROP.NS balance_sheet (annual, 2024-03-31) — Share Issued: 44942092.00
BAYERCROP.NS income_statement (annual, 2024-03-31) — Special Income Charges: -253000000.00
BAYERCROP.NS balance_sheet (annual, 2024-03-31) — Stockholders Equity: 28494000000.00
BAYERCROP.NS balance_sheet (annual, 2024-03-31) — Tangible Book Value: 27240000000.00
BAYERCROP.NS income_statement (annual, 2024-03-31) — Tax Effect Of Unusual Items: -22407584.45
BAYERCROP.NS income_statement (annual, 2024-03-31) — Tax Provision: 2009000000.00
BAYERCROP.NS income_statement (annual, 2024-03-31) — Tax Rate For Calcs: 0.21
BAYERCROP.NS cash_flow (annual, 2024-03-31) — Taxes Refund Paid: -1321000000.00
BAYERCROP.NS balance_sheet (annual, 2024-03-31) — Total Assets: 45971000000.00
BAYERCROP.NS balance_sheet (annual, 2024-03-31) — Total Capitalization: 28494000000.00
BAYERCROP.NS balance_sheet (annual, 2024-03-31) — Total Debt: 471000000.00
BAYERCROP.NS balance_sheet (annual, 2024-03-31) — Total Equity Gross Minority Interest: 28494000000.00
BAYERCROP.NS income_statement (annual, 2024-03-31) — Total Expenses: 39836000000.00
BAYERCROP.NS balance_sheet (annual, 2024-03-31) — Total Liabilities Net Minority Interest: 17477000000.00
BAYERCROP.NS balance_sheet (annual, 2024-03-31) — Total Non Current Assets: 6916000000.00
BAYERCROP.NS balance_sheet (annual, 2024-03-31) — Total Non Current Liabilities Net Minority Interest: 1503000000.00
BAYERCROP.NS balance_sheet (annual, 2024-03-31) — Total Tax Payable: 19000000.00
BAYERCROP.NS income_statement (annual, 2024-03-31) — Total Unusual Items: -105000000.00
BAYERCROP.NS income_statement (annual, 2024-03-31) — Total Unusual Items Excluding Goodwill: -105000000.00
BAYERCROP.NS balance_sheet (annual, 2024-03-31) — Work In Process: 2093000000.00
BAYERCROP.NS balance_sheet (annual, 2024-03-31) — Working Capital: 23081000000.00
BAYERCROP.NS income_statement (annual, 2024-03-31) — Write Off: 38000000.00
BAYERCROP.NS balance_sheet (quarterly, 2024-09-30) — Accounts Payable: 8580000000.00
BAYERCROP.NS balance_sheet (quarterly, 2024-09-30) — Accounts Receivable: 19609000000.00
BAYERCROP.NS balance_sheet (quarterly, 2024-09-30) — Available For Sale Securities: 58000000.00
BAYERCROP.NS balance_sheet (quarterly, 2024-09-30) — Capital Lease Obligations: 334000000.00
BAYERCROP.NS balance_sheet (quarterly, 2024-09-30) — Capital Stock: 449000000.00
BAYERCROP.NS balance_sheet (quarterly, 2024-09-30) — Cash And Cash Equivalents: 9099000000.00
BAYERCROP.NS balance_sheet (quarterly, 2024-09-30) — Cash Cash Equivalents And Short Term Investments: 9894000000.00
BAYERCROP.NS balance_sheet (quarterly, 2024-09-30) — Common Stock: 449000000.00
BAYERCROP.NS balance_sheet (quarterly, 2024-09-30) — Common Stock Equity: 30822000000.00
BAYERCROP.NS balance_sheet (quarterly, 2024-09-30) — Construction In Progress: 15000000.00
BAYERCROP.NS balance_sheet (quarterly, 2024-09-30) — Current Assets: 45869000000.00
BAYERCROP.NS balance_sheet (quarterly, 2024-09-30) — Current Capital Lease Obligation: 185000000.00
BAYERCROP.NS balance_sheet (quarterly, 2024-09-30) — Current Debt And Capital Lease Obligation: 185000000.00
BAYERCROP.NS balance_sheet (quarterly, 2024-09-30) — Current Liabilities: 20634000000.00
BAYERCROP.NS balance_sheet (quarterly, 2024-09-30) — Current Provisions: 602000000.00
BAYERCROP.NS balance_sheet (quarterly, 2024-09-30) — Goodwill And Other Intangible Assets: 1321000000.00
BAYERCROP.NS balance_sheet (quarterly, 2024-09-30) — Gross PPE: 3607000000.00
BAYERCROP.NS income_statement (quarterly, 2024-09-30) — Impairment Of Capital Assets: 0.00
BAYERCROP.NS balance_sheet (quarterly, 2024-09-30) — Inventory: 13400000000.00
BAYERCROP.NS balance_sheet (quarterly, 2024-09-30) — Invested Capital: 30822000000.00
BAYERCROP.NS balance_sheet (quarterly, 2024-09-30) — Investment Properties: 249000000.00
BAYERCROP.NS balance_sheet (quarterly, 2024-09-30) — Investmentin Financial Assets: 58000000.00
BAYERCROP.NS balance_sheet (quarterly, 2024-09-30) — Long Term Capital Lease Obligation: 149000000.00
BAYERCROP.NS balance_sheet (quarterly, 2024-09-30) — Long Term Debt And Capital Lease Obligation: 149000000.00
BAYERCROP.NS balance_sheet (quarterly, 2024-09-30) — Long Term Provisions: 1051000000.00
BAYERCROP.NS balance_sheet (quarterly, 2024-09-30) — Net PPE: 3607000000.00
BAYERCROP.NS balance_sheet (quarterly, 2024-09-30) — Net Tangible Assets: 29501000000.00
BAYERCROP.NS balance_sheet (quarterly, 2024-09-30) — Non Current Deferred Taxes Liabilities: 49000000.00
BAYERCROP.NS balance_sheet (quarterly, 2024-09-30) — Ordinary Shares Number: 44942092.00
BAYERCROP.NS balance_sheet (quarterly, 2024-09-30) — Other Current Assets: 2966000000.00
BAYERCROP.NS balance_sheet (quarterly, 2024-09-30) — Other Current Liabilities: 10597000000.00
BAYERCROP.NS balance_sheet (quarterly, 2024-09-30) — Other Equity Interest: 30373000000.00
BAYERCROP.NS balance_sheet (quarterly, 2024-09-30) — Other Intangible Assets: 1321000000.00
BAYERCROP.NS balance_sheet (quarterly, 2024-09-30) — Other Non Current Assets: 426000000.00
BAYERCROP.NS balance_sheet (quarterly, 2024-09-30) — Other Properties: 3592000000.00
BAYERCROP.NS balance_sheet (quarterly, 2024-09-30) — Other Short Term Investments: 795000000.00
BAYERCROP.NS balance_sheet (quarterly, 2024-09-30) — Payables: 8793000000.00
BAYERCROP.NS balance_sheet (quarterly, 2024-09-30) — Share Issued: 44942092.00
BAYERCROP.NS income_statement (quarterly, 2024-09-30) — Special Income Charges: 0.00
BAYERCROP.NS balance_sheet (quarterly, 2024-09-30) — Stockholders Equity: 30822000000.00
BAYERCROP.NS balance_sheet (quarterly, 2024-09-30) — Tangible Book Value: 29501000000.00
BAYERCROP.NS balance_sheet (quarterly, 2024-09-30) — Total Assets: 52705000000.00
BAYERCROP.NS balance_sheet (quarterly, 2024-09-30) — Total Capitalization: 30822000000.00
BAYERCROP.NS balance_sheet (quarterly, 2024-09-30) — Total Debt: 334000000.00
BAYERCROP.NS balance_sheet (quarterly, 2024-09-30) — Total Equity Gross Minority Interest: 30822000000.00
BAYERCROP.NS balance_sheet (quarterly, 2024-09-30) — Total Liabilities Net Minority Interest: 21883000000.00
BAYERCROP.NS balance_sheet (quarterly, 2024-09-30) — Total Non Current Assets: 6836000000.00
BAYERCROP.NS balance_sheet (quarterly, 2024-09-30) — Total Non Current Liabilities Net Minority Interest: 1249000000.00
BAYERCROP.NS balance_sheet (quarterly, 2024-09-30) — Total Tax Payable: 213000000.00
BAYERCROP.NS income_statement (quarterly, 2024-09-30) — Total Unusual Items: 0.00
BAYERCROP.NS income_statement (quarterly, 2024-09-30) — Total Unusual Items Excluding Goodwill: 0.00
BAYERCROP.NS balance_sheet (quarterly, 2024-09-30) — Working Capital: 25235000000.00
BAYERCROP.NS income_statement (quarterly, 2024-12-31) — Impairment Of Capital Assets: 0.00
BAYERCROP.NS income_statement (quarterly, 2024-12-31) — Special Income Charges: 0.00
BAYERCROP.NS income_statement (quarterly, 2024-12-31) — Total Unusual Items: 0.00
BAYERCROP.NS income_statement (quarterly, 2024-12-31) — Total Unusual Items Excluding Goodwill: 0.00
BAYERCROP.NS income_statement (annual, 2025-03-31) — +Operating Expense: 12757000000.00
BAYERCROP.NS income_statement (quarterly, 2025-03-31) — +Operating Expense: 3458000000.00
BAYERCROP.NS income_statement (annual, 2025-03-31) — +Total Revenue: 53141000000.00
BAYERCROP.NS income_statement (quarterly, 2025-03-31) — +Total Revenue: 10464000000.00
BAYERCROP.NS balance_sheet (annual, 2025-03-31) — Accounts Payable: 10984000000.00
BAYERCROP.NS balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 10984000000.00
BAYERCROP.NS balance_sheet (annual, 2025-03-31) — Accounts Receivable: 9521000000.00
BAYERCROP.NS balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 9521000000.00
BAYERCROP.NS balance_sheet (annual, 2025-03-31) — Accumulated Depreciation: -3842000000.00
BAYERCROP.NS balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -3842000000.00
BAYERCROP.NS balance_sheet (annual, 2025-03-31) — Additional Paid In Capital: 1446000000.00
BAYERCROP.NS balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 1446000000.00
BAYERCROP.NS balance_sheet (annual, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -90000000.00
BAYERCROP.NS balance_sheet (quarterly, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -90000000.00
BAYERCROP.NS income_statement (annual, 2025-03-31) — Amortization: 29000000.00
BAYERCROP.NS cash_flow (annual, 2025-03-31) — Amortization Cash Flow: 29000000.00
BAYERCROP.NS balance_sheet (annual, 2025-03-31) — Available For Sale Securities: 48000000.00
BAYERCROP.NS balance_sheet (quarterly, 2025-03-31) — Available For Sale Securities: 48000000.00
BAYERCROP.NS income_statement (annual, 2025-03-31) — Basic Average Shares: 44942092.00
BAYERCROP.NS income_statement (quarterly, 2025-03-31) — Basic Average Shares: 44949812.00
BAYERCROP.NS income_statement (annual, 2025-03-31) — Basic EPS: 126.38
BAYERCROP.NS income_statement (quarterly, 2025-03-31) — Basic EPS: 31.88
BAYERCROP.NS cash_flow (annual, 2025-03-31) — Beginning Cash Position: 11568000000.00
BAYERCROP.NS balance_sheet (annual, 2025-03-31) — Buildings And Improvements: 3085000000.00
BAYERCROP.NS balance_sheet (quarterly, 2025-03-31) — Buildings And Improvements: 3085000000.00
BAYERCROP.NS cash_flow (annual, 2025-03-31) — Capital Expenditure: -434000000.00
BAYERCROP.NS balance_sheet (annual, 2025-03-31) — Capital Lease Obligations: 1051000000.00
BAYERCROP.NS balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 1051000000.00
BAYERCROP.NS balance_sheet (annual, 2025-03-31) — Capital Stock: 449000000.00
BAYERCROP.NS balance_sheet (quarterly, 2025-03-31) — Capital Stock: 449000000.00
BAYERCROP.NS balance_sheet (annual, 2025-03-31) — Cash And Cash Equivalents: 8855000000.00
BAYERCROP.NS balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 8855000000.00
BAYERCROP.NS balance_sheet (annual, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 9209000000.00
BAYERCROP.NS balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 9209000000.00
BAYERCROP.NS cash_flow (annual, 2025-03-31) — Cash Dividends Paid: -5608000000.00
BAYERCROP.NS balance_sheet (annual, 2025-03-31) — Cash Equivalents: 8787000000.00
BAYERCROP.NS balance_sheet (quarterly, 2025-03-31) — Cash Equivalents: 8787000000.00
BAYERCROP.NS balance_sheet (annual, 2025-03-31) — Cash Financial: 68000000.00
BAYERCROP.NS balance_sheet (quarterly, 2025-03-31) — Cash Financial: 68000000.00
BAYERCROP.NS cash_flow (annual, 2025-03-31) — Change In Inventory: -8208000000.00
BAYERCROP.NS cash_flow (annual, 2025-03-31) — Change In Other Current Assets: -549000000.00
BAYERCROP.NS cash_flow (annual, 2025-03-31) — Change In Other Current Liabilities: 819000000.00
BAYERCROP.NS cash_flow (annual, 2025-03-31) — Change In Payable: 4933000000.00
BAYERCROP.NS cash_flow (annual, 2025-03-31) — Change In Receivables: -717000000.00
BAYERCROP.NS cash_flow (annual, 2025-03-31) — Change In Working Capital: -3651000000.00
BAYERCROP.NS cash_flow (annual, 2025-03-31) — Changes In Cash: -2718000000.00
BAYERCROP.NS balance_sheet (annual, 2025-03-31) — Common Stock: 449000000.00
BAYERCROP.NS balance_sheet (quarterly, 2025-03-31) — Common Stock: 449000000.00
BAYERCROP.NS balance_sheet (annual, 2025-03-31) — Common Stock Equity: 28504000000.00
BAYERCROP.NS balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 28504000000.00
BAYERCROP.NS balance_sheet (annual, 2025-03-31) — Construction In Progress: 25000000.00
BAYERCROP.NS balance_sheet (quarterly, 2025-03-31) — Construction In Progress: 25000000.00
BAYERCROP.NS income_statement (annual, 2025-03-31) — Cost Of Revenue: 34290000000.00
BAYERCROP.NS income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 5641000000.00
BAYERCROP.NS balance_sheet (annual, 2025-03-31) — Current Assets: 44716000000.00
BAYERCROP.NS balance_sheet (quarterly, 2025-03-31) — Current Assets: 44716000000.00
BAYERCROP.NS balance_sheet (annual, 2025-03-31) — Current Capital Lease Obligation: 435000000.00
BAYERCROP.NS balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 435000000.00
BAYERCROP.NS balance_sheet (annual, 2025-03-31) — Current Debt And Capital Lease Obligation: 435000000.00
BAYERCROP.NS balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 435000000.00
BAYERCROP.NS balance_sheet (annual, 2025-03-31) — Current Deferred Taxes Liabilities: 17000000.00
BAYERCROP.NS balance_sheet (quarterly, 2025-03-31) — Current Deferred Taxes Liabilities: 17000000.00
BAYERCROP.NS balance_sheet (annual, 2025-03-31) — Current Liabilities: 22237000000.00
BAYERCROP.NS balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 22237000000.00
BAYERCROP.NS balance_sheet (annual, 2025-03-31) — Current Provisions: 871000000.00
BAYERCROP.NS balance_sheet (quarterly, 2025-03-31) — Current Provisions: 871000000.00
BAYERCROP.NS cash_flow (annual, 2025-03-31) — Depreciation: 820000000.00
BAYERCROP.NS cash_flow (annual, 2025-03-31) — Depreciation And Amortization: 849000000.00
BAYERCROP.NS income_statement (annual, 2025-03-31) — Depreciation And Amortization In Income Statement: 849000000.00
BAYERCROP.NS income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 343000000.00
BAYERCROP.NS income_statement (annual, 2025-03-31) — Depreciation Income Statement: 820000000.00
BAYERCROP.NS income_statement (quarterly, 2025-03-31) — Depreciation Income Statement: 343000000.00
BAYERCROP.NS income_statement (annual, 2025-03-31) — Diluted Average Shares: 44942092.00
BAYERCROP.NS income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 44949812.00
BAYERCROP.NS income_statement (annual, 2025-03-31) — Diluted EPS: 126.38
BAYERCROP.NS income_statement (quarterly, 2025-03-31) — Diluted EPS: 31.88
BAYERCROP.NS income_statement (annual, 2025-03-31) — Diluted NI Availto Com Stockholders: 5680000000.00
BAYERCROP.NS income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 1433000000.00
BAYERCROP.NS balance_sheet (annual, 2025-03-31) — Dividends Payable: 75000000.00
BAYERCROP.NS balance_sheet (quarterly, 2025-03-31) — Dividends Payable: 75000000.00
BAYERCROP.NS income_statement (annual, 2025-03-31) — EBIT: 7244000000.00
BAYERCROP.NS income_statement (quarterly, 2025-03-31) — EBIT: 1736000000.00
BAYERCROP.NS income_statement (annual, 2025-03-31) — EBITDA: 8093000000.00
BAYERCROP.NS income_statement (quarterly, 2025-03-31) — EBITDA: 2079000000.00
BAYERCROP.NS cash_flow (annual, 2025-03-31) — End Cash Position: 8850000000.00
BAYERCROP.NS cash_flow (annual, 2025-03-31) — Financing Cash Flow: -6194000000.00
BAYERCROP.NS balance_sheet (annual, 2025-03-31) — Finished Goods: 7013000000.00
BAYERCROP.NS balance_sheet (quarterly, 2025-03-31) — Finished Goods: 7013000000.00
BAYERCROP.NS cash_flow (annual, 2025-03-31) — Free Cash Flow: 2186000000.00
BAYERCROP.NS cash_flow (annual, 2025-03-31) — Gain Loss On Investment Securities: -191000000.00
BAYERCROP.NS cash_flow (annual, 2025-03-31) — Gain Loss On Sale Of PPE: 12000000.00
BAYERCROP.NS income_statement (annual, 2025-03-31) — General And Administrative Expense: 1348000000.00
BAYERCROP.NS balance_sheet (annual, 2025-03-31) — Goodwill And Other Intangible Assets: 1364000000.00
BAYERCROP.NS balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 1364000000.00
BAYERCROP.NS balance_sheet (annual, 2025-03-31) — Gross Accounts Receivable: 9611000000.00
BAYERCROP.NS balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 9611000000.00
BAYERCROP.NS balance_sheet (annual, 2025-03-31) — Gross PPE: 8136000000.00
BAYERCROP.NS balance_sheet (quarterly, 2025-03-31) — Gross PPE: 8136000000.00
BAYERCROP.NS income_statement (annual, 2025-03-31) — Gross Profit: 18851000000.00
BAYERCROP.NS income_statement (quarterly, 2025-03-31) — Gross Profit: 4823000000.00
BAYERCROP.NS income_statement (annual, 2025-03-31) — Impairment Of Capital Assets: 0.00
BAYERCROP.NS income_statement (quarterly, 2025-03-31) — Impairment Of Capital Assets: 0.00
BAYERCROP.NS income_statement (annual, 2025-03-31) — Interest Expense: 170000000.00
BAYERCROP.NS income_statement (quarterly, 2025-03-31) — Interest Expense: 57000000.00
BAYERCROP.NS income_statement (annual, 2025-03-31) — Interest Expense Non Operating: 170000000.00
BAYERCROP.NS income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 57000000.00
BAYERCROP.NS income_statement (annual, 2025-03-31) — Interest Income: 566000000.00
BAYERCROP.NS income_statement (annual, 2025-03-31) — Interest Income Non Operating: 566000000.00
BAYERCROP.NS cash_flow (annual, 2025-03-31) — Interest Paid Cff: -85000000.00
BAYERCROP.NS cash_flow (annual, 2025-03-31) — Interest Received Cfi: 467000000.00
BAYERCROP.NS balance_sheet (annual, 2025-03-31) — Inventory: 23618000000.00
BAYERCROP.NS balance_sheet (quarterly, 2025-03-31) — Inventory: 23618000000.00
BAYERCROP.NS balance_sheet (annual, 2025-03-31) — Invested Capital: 28504000000.00
BAYERCROP.NS balance_sheet (quarterly, 2025-03-31) — Invested Capital: 28504000000.00
BAYERCROP.NS cash_flow (annual, 2025-03-31) — Investing Cash Flow: 856000000.00
BAYERCROP.NS balance_sheet (annual, 2025-03-31) — Investment Properties: 246000000.00
BAYERCROP.NS balance_sheet (quarterly, 2025-03-31) — Investment Properties: 246000000.00
BAYERCROP.NS balance_sheet (annual, 2025-03-31) — Investmentin Financial Assets: 48000000.00
BAYERCROP.NS balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 48000000.00
BAYERCROP.NS balance_sheet (annual, 2025-03-31) — Land And Improvements: 361000000.00
BAYERCROP.NS balance_sheet (quarterly, 2025-03-31) — Land And Improvements: 361000000.00
BAYERCROP.NS balance_sheet (annual, 2025-03-31) — Long Term Capital Lease Obligation: 616000000.00
BAYERCROP.NS balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 616000000.00
BAYERCROP.NS balance_sheet (annual, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 616000000.00
BAYERCROP.NS balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 616000000.00
BAYERCROP.NS balance_sheet (annual, 2025-03-31) — Long Term Provisions: 1102000000.00
BAYERCROP.NS balance_sheet (quarterly, 2025-03-31) — Long Term Provisions: 1102000000.00
BAYERCROP.NS balance_sheet (annual, 2025-03-31) — Machinery Furniture Equipment: 3763000000.00
BAYERCROP.NS balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 3763000000.00
BAYERCROP.NS cash_flow (annual, 2025-03-31) — Net Foreign Currency Exchange Gain Loss: 4000000.00
BAYERCROP.NS income_statement (annual, 2025-03-31) — Net Income: 5680000000.00
BAYERCROP.NS income_statement (quarterly, 2025-03-31) — Net Income: 1433000000.00
BAYERCROP.NS income_statement (annual, 2025-03-31) — Net Income Common Stockholders: 5680000000.00
BAYERCROP.NS income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 1433000000.00
BAYERCROP.NS income_statement (annual, 2025-03-31) — Net Income Continuous Operations: 5680000000.00
BAYERCROP.NS income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 1433000000.00
BAYERCROP.NS income_statement (annual, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 5680000000.00
BAYERCROP.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 1433000000.00
BAYERCROP.NS income_statement (annual, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 5680000000.00
BAYERCROP.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 1433000000.00
BAYERCROP.NS cash_flow (annual, 2025-03-31) — Net Income From Continuing Operations: 7074000000.00
BAYERCROP.NS income_statement (annual, 2025-03-31) — Net Income Including Noncontrolling Interests: 5680000000.00
BAYERCROP.NS income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 1433000000.00
BAYERCROP.NS cash_flow (annual, 2025-03-31) — Net Intangibles Purchase And Sale: -176000000.00
BAYERCROP.NS income_statement (annual, 2025-03-31) — Net Interest Income: 396000000.00
BAYERCROP.NS income_statement (quarterly, 2025-03-31) — Net Interest Income: -57000000.00
BAYERCROP.NS cash_flow (annual, 2025-03-31) — Net Investment Purchase And Sale: 371000000.00
BAYERCROP.NS income_statement (annual, 2025-03-31) — Net Non Operating Interest Income Expense: 396000000.00
BAYERCROP.NS income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -57000000.00
BAYERCROP.NS cash_flow (annual, 2025-03-31) — Net Other Financing Charges: -10000000.00
BAYERCROP.NS cash_flow (annual, 2025-03-31) — Net Other Investing Changes: 418000000.00
BAYERCROP.NS balance_sheet (annual, 2025-03-31) — Net PPE: 4294000000.00
BAYERCROP.NS balance_sheet (quarterly, 2025-03-31) — Net PPE: 4294000000.00
BAYERCROP.NS cash_flow (annual, 2025-03-31) — Net PPE Purchase And Sale: -224000000.00
BAYERCROP.NS balance_sheet (annual, 2025-03-31) — Net Tangible Assets: 27140000000.00
BAYERCROP.NS balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 27140000000.00
BAYERCROP.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Taxes Assets: 97000000.00
BAYERCROP.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Assets: 97000000.00
BAYERCROP.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Taxes Liabilities: 0.00
BAYERCROP.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 0.00
BAYERCROP.NS balance_sheet (annual, 2025-03-31) — Non Current Prepaid Assets: 1741000000.00
BAYERCROP.NS balance_sheet (quarterly, 2025-03-31) — Non Current Prepaid Assets: 1741000000.00
BAYERCROP.NS income_statement (annual, 2025-03-31) — Normalized EBITDA: 7673000000.00
BAYERCROP.NS income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 2079000000.00
BAYERCROP.NS income_statement (annual, 2025-03-31) — Normalized Income: 5342765055.13
BAYERCROP.NS income_statement (quarterly, 2025-03-31) — Normalized Income: 1433000000.00
BAYERCROP.NS cash_flow (annual, 2025-03-31) — Operating Cash Flow: 2620000000.00
BAYERCROP.NS income_statement (annual, 2025-03-31) — Operating Income: 6094000000.00
BAYERCROP.NS income_statement (quarterly, 2025-03-31) — Operating Income: 1365000000.00
BAYERCROP.NS income_statement (annual, 2025-03-31) — Operating Revenue: 53141000000.00
BAYERCROP.NS income_statement (quarterly, 2025-03-31) — Operating Revenue: 10464000000.00
BAYERCROP.NS balance_sheet (annual, 2025-03-31) — Ordinary Shares Number: 44942092.00
BAYERCROP.NS balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 44942092.00
BAYERCROP.NS balance_sheet (annual, 2025-03-31) — Other Current Assets: 434000000.00
BAYERCROP.NS balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 434000000.00
BAYERCROP.NS balance_sheet (annual, 2025-03-31) — Other Current Liabilities: 817000000.00
BAYERCROP.NS balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 817000000.00
BAYERCROP.NS balance_sheet (annual, 2025-03-31) — Other Equity Interest: 28055000000.00
BAYERCROP.NS balance_sheet (quarterly, 2025-03-31) — Other Equity Interest: 28055000000.00
BAYERCROP.NS balance_sheet (annual, 2025-03-31) — Other Intangible Assets: 1364000000.00
BAYERCROP.NS balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 1364000000.00
BAYERCROP.NS balance_sheet (annual, 2025-03-31) — Other Inventories: 649000000.00
BAYERCROP.NS balance_sheet (quarterly, 2025-03-31) — Other Inventories: 649000000.00
BAYERCROP.NS cash_flow (annual, 2025-03-31) — Other Non Cash Items: -696000000.00
BAYERCROP.NS balance_sheet (annual, 2025-03-31) — Other Non Current Assets: 421000000.00
BAYERCROP.NS balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 421000000.00
BAYERCROP.NS income_statement (annual, 2025-03-31) — Other Non Operating Income Expenses: 166000000.00
BAYERCROP.NS income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 371000000.00
BAYERCROP.NS income_statement (annual, 2025-03-31) — Other Operating Expenses: 3260000000.00
BAYERCROP.NS income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 2003000000.00
BAYERCROP.NS balance_sheet (annual, 2025-03-31) — Other Payable: 5248000000.00
BAYERCROP.NS balance_sheet (quarterly, 2025-03-31) — Other Payable: 5248000000.00
BAYERCROP.NS balance_sheet (annual, 2025-03-31) — Other Properties: 902000000.00
BAYERCROP.NS balance_sheet (quarterly, 2025-03-31) — Other Properties: 902000000.00
BAYERCROP.NS balance_sheet (annual, 2025-03-31) — Other Receivables: 52000000.00
BAYERCROP.NS balance_sheet (quarterly, 2025-03-31) — Other Receivables: 52000000.00
BAYERCROP.NS balance_sheet (annual, 2025-03-31) — Other Short Term Investments: 354000000.00
BAYERCROP.NS balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 354000000.00
BAYERCROP.NS income_statement (annual, 2025-03-31) — Other Special Charges: -256000000.00
BAYERCROP.NS income_statement (annual, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
BAYERCROP.NS income_statement (quarterly, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
BAYERCROP.NS balance_sheet (annual, 2025-03-31) — Payables: 16307000000.00
BAYERCROP.NS balance_sheet (quarterly, 2025-03-31) — Payables: 16307000000.00
BAYERCROP.NS balance_sheet (annual, 2025-03-31) — Prepaid Assets: 1800000000.00
BAYERCROP.NS balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 1800000000.00
BAYERCROP.NS income_statement (annual, 2025-03-31) — Pretax Income: 7074000000.00
BAYERCROP.NS income_statement (quarterly, 2025-03-31) — Pretax Income: 1679000000.00
BAYERCROP.NS balance_sheet (annual, 2025-03-31) — Properties: 0.00
BAYERCROP.NS balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
BAYERCROP.NS cash_flow (annual, 2025-03-31) — Provisionand Write Offof Assets: 768000000.00
BAYERCROP.NS cash_flow (annual, 2025-03-31) — Purchase Of Intangibles: -176000000.00
BAYERCROP.NS cash_flow (annual, 2025-03-31) — Purchase Of PPE: -258000000.00
BAYERCROP.NS balance_sheet (annual, 2025-03-31) — Raw Materials: 12043000000.00
BAYERCROP.NS balance_sheet (quarterly, 2025-03-31) — Raw Materials: 12043000000.00
BAYERCROP.NS income_statement (annual, 2025-03-31) — Reconciled Cost Of Revenue: 34290000000.00
BAYERCROP.NS income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 5641000000.00
BAYERCROP.NS income_statement (annual, 2025-03-31) — Reconciled Depreciation: 849000000.00
BAYERCROP.NS income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 343000000.00
BAYERCROP.NS income_statement (annual, 2025-03-31) — Rent And Landing Fees: 102000000.00
BAYERCROP.NS income_statement (annual, 2025-03-31) — Rent Expense Supplemental: 102000000.00
BAYERCROP.NS balance_sheet (annual, 2025-03-31) — Restricted Cash: 82000000.00
BAYERCROP.NS balance_sheet (quarterly, 2025-03-31) — Restricted Cash: 82000000.00
BAYERCROP.NS balance_sheet (annual, 2025-03-31) — Retained Earnings: 23081000000.00
BAYERCROP.NS balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 23081000000.00
BAYERCROP.NS cash_flow (annual, 2025-03-31) — Sale Of Investment: 664000000.00
BAYERCROP.NS cash_flow (annual, 2025-03-31) — Sale Of PPE: 34000000.00
BAYERCROP.NS income_statement (annual, 2025-03-31) — Selling And Marketing Expense: 4061000000.00
BAYERCROP.NS income_statement (annual, 2025-03-31) — Selling General And Administration: 5409000000.00
BAYERCROP.NS balance_sheet (annual, 2025-03-31) — Share Issued: 44942092.00
BAYERCROP.NS balance_sheet (quarterly, 2025-03-31) — Share Issued: 44942092.00
BAYERCROP.NS income_statement (annual, 2025-03-31) — Special Income Charges: 229000000.00
BAYERCROP.NS income_statement (quarterly, 2025-03-31) — Special Income Charges: 229000000.00
BAYERCROP.NS balance_sheet (annual, 2025-03-31) — Stockholders Equity: 28504000000.00
BAYERCROP.NS balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 28504000000.00
BAYERCROP.NS balance_sheet (annual, 2025-03-31) — Tangible Book Value: 27140000000.00
BAYERCROP.NS balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 27140000000.00
BAYERCROP.NS income_statement (annual, 2025-03-31) — Tax Effect Of Unusual Items: 82765055.13
BAYERCROP.NS income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
BAYERCROP.NS income_statement (annual, 2025-03-31) — Tax Provision: 1394000000.00
BAYERCROP.NS income_statement (quarterly, 2025-03-31) — Tax Provision: 246000000.00
BAYERCROP.NS income_statement (annual, 2025-03-31) — Tax Rate For Calcs: 0.20
BAYERCROP.NS income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.15
BAYERCROP.NS cash_flow (annual, 2025-03-31) — Taxes Refund Paid: -1618000000.00
BAYERCROP.NS balance_sheet (annual, 2025-03-31) — Total Assets: 52459000000.00
BAYERCROP.NS balance_sheet (quarterly, 2025-03-31) — Total Assets: 52459000000.00
BAYERCROP.NS balance_sheet (annual, 2025-03-31) — Total Capitalization: 28504000000.00
BAYERCROP.NS balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 28504000000.00
BAYERCROP.NS balance_sheet (annual, 2025-03-31) — Total Debt: 1051000000.00
BAYERCROP.NS balance_sheet (quarterly, 2025-03-31) — Total Debt: 1051000000.00
BAYERCROP.NS balance_sheet (annual, 2025-03-31) — Total Equity Gross Minority Interest: 28504000000.00
BAYERCROP.NS balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 28504000000.00
BAYERCROP.NS income_statement (annual, 2025-03-31) — Total Expenses: 47047000000.00
BAYERCROP.NS income_statement (quarterly, 2025-03-31) — Total Expenses: 9099000000.00
BAYERCROP.NS balance_sheet (annual, 2025-03-31) — Total Liabilities Net Minority Interest: 23955000000.00
BAYERCROP.NS balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 23955000000.00
BAYERCROP.NS balance_sheet (annual, 2025-03-31) — Total Non Current Assets: 7743000000.00
BAYERCROP.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 7743000000.00
BAYERCROP.NS balance_sheet (annual, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 1718000000.00
BAYERCROP.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 1718000000.00
BAYERCROP.NS balance_sheet (annual, 2025-03-31) — Total Tax Payable: 17000000.00
BAYERCROP.NS balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 17000000.00
BAYERCROP.NS income_statement (annual, 2025-03-31) — Total Unusual Items: 420000000.00
BAYERCROP.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items: 420000000.00
BAYERCROP.NS income_statement (annual, 2025-03-31) — Total Unusual Items Excluding Goodwill: 420000000.00
BAYERCROP.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 420000000.00
BAYERCROP.NS balance_sheet (annual, 2025-03-31) — Work In Process: 3913000000.00
BAYERCROP.NS balance_sheet (quarterly, 2025-03-31) — Work In Process: 3913000000.00
BAYERCROP.NS balance_sheet (annual, 2025-03-31) — Working Capital: 22479000000.00
BAYERCROP.NS balance_sheet (quarterly, 2025-03-31) — Working Capital: 22479000000.00
BAYERCROP.NS income_statement (annual, 2025-03-31) — Write Off: 27000000.00
BAYERCROP.NS income_statement (quarterly, 2025-06-30) — +Operating Expense: 4229000000.00
BAYERCROP.NS income_statement (quarterly, 2025-06-30) — +Total Revenue: 19146000000.00
BAYERCROP.NS income_statement (quarterly, 2025-06-30) — Basic Average Shares: 44944364.00
BAYERCROP.NS income_statement (quarterly, 2025-06-30) — Basic EPS: 62.01
BAYERCROP.NS income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 11705000000.00
BAYERCROP.NS income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 272000000.00
BAYERCROP.NS income_statement (quarterly, 2025-06-30) — Depreciation Income Statement: 272000000.00
BAYERCROP.NS income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 44944364.00
BAYERCROP.NS income_statement (quarterly, 2025-06-30) — Diluted EPS: 62.01
BAYERCROP.NS income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 2787000000.00
BAYERCROP.NS income_statement (quarterly, 2025-06-30) — EBIT: 3399000000.00
BAYERCROP.NS income_statement (quarterly, 2025-06-30) — EBITDA: 3671000000.00
BAYERCROP.NS income_statement (quarterly, 2025-06-30) — Gross Profit: 7441000000.00
BAYERCROP.NS income_statement (quarterly, 2025-06-30) — Interest Expense: 47000000.00
BAYERCROP.NS income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 47000000.00
BAYERCROP.NS income_statement (quarterly, 2025-06-30) — Net Income: 2787000000.00
BAYERCROP.NS income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 2787000000.00
BAYERCROP.NS income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 2787000000.00
BAYERCROP.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 2787000000.00
BAYERCROP.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 2787000000.00
BAYERCROP.NS income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 2787000000.00
BAYERCROP.NS income_statement (quarterly, 2025-06-30) — Net Interest Income: -47000000.00
BAYERCROP.NS income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -47000000.00
BAYERCROP.NS income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 3671000000.00
BAYERCROP.NS income_statement (quarterly, 2025-06-30) — Normalized Income: 2787000000.00
BAYERCROP.NS income_statement (quarterly, 2025-06-30) — Operating Income: 3212000000.00
BAYERCROP.NS income_statement (quarterly, 2025-06-30) — Operating Revenue: 19146000000.00
BAYERCROP.NS income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 187000000.00
BAYERCROP.NS income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 2914000000.00
BAYERCROP.NS income_statement (quarterly, 2025-06-30) — Otherunder Preferred Stock Dividend: 0.00
BAYERCROP.NS income_statement (quarterly, 2025-06-30) — Pretax Income: 3352000000.00
BAYERCROP.NS income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 11705000000.00
BAYERCROP.NS income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 272000000.00
BAYERCROP.NS income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
BAYERCROP.NS income_statement (quarterly, 2025-06-30) — Tax Provision: 565000000.00
BAYERCROP.NS income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.17
BAYERCROP.NS income_statement (quarterly, 2025-06-30) — Total Expenses: 15934000000.00
BAYERCROP.NS income_statement (quarterly, 2025-09-30) — +Operating Expense: 3409000000.00
BAYERCROP.NS income_statement (quarterly, 2025-09-30) — +Total Revenue: 15534000000.00
BAYERCROP.NS balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 5431000000.00
BAYERCROP.NS balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 17663000000.00
BAYERCROP.NS balance_sheet (quarterly, 2025-09-30) — Available For Sale Securities: 48000000.00
BAYERCROP.NS income_statement (quarterly, 2025-09-30) — Basic Average Shares: 44938199.00
BAYERCROP.NS income_statement (quarterly, 2025-09-30) — Basic EPS: 33.98
BAYERCROP.NS balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 1020000000.00
BAYERCROP.NS balance_sheet (quarterly, 2025-09-30) — Capital Stock: 449000000.00
BAYERCROP.NS balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 6579000000.00
BAYERCROP.NS balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 7164000000.00
BAYERCROP.NS balance_sheet (quarterly, 2025-09-30) — Common Stock: 449000000.00
BAYERCROP.NS balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 31235000000.00
BAYERCROP.NS balance_sheet (quarterly, 2025-09-30) — Construction In Progress: 88000000.00
BAYERCROP.NS income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 10216000000.00
BAYERCROP.NS balance_sheet (quarterly, 2025-09-30) — Current Assets: 43997000000.00
BAYERCROP.NS balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 453000000.00
BAYERCROP.NS balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 453000000.00
BAYERCROP.NS balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 19172000000.00
BAYERCROP.NS balance_sheet (quarterly, 2025-09-30) — Current Provisions: 766000000.00
BAYERCROP.NS income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 144000000.00
BAYERCROP.NS income_statement (quarterly, 2025-09-30) — Depreciation Income Statement: 144000000.00
BAYERCROP.NS income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 44938199.00
BAYERCROP.NS income_statement (quarterly, 2025-09-30) — Diluted EPS: 33.98
BAYERCROP.NS income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 1527000000.00
BAYERCROP.NS income_statement (quarterly, 2025-09-30) — EBIT: 2047000000.00
BAYERCROP.NS income_statement (quarterly, 2025-09-30) — EBITDA: 2191000000.00
BAYERCROP.NS balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 1479000000.00
BAYERCROP.NS balance_sheet (quarterly, 2025-09-30) — Gross PPE: 4211000000.00
BAYERCROP.NS income_statement (quarterly, 2025-09-30) — Gross Profit: 5318000000.00
BAYERCROP.NS income_statement (quarterly, 2025-09-30) — Interest Expense: 44000000.00
BAYERCROP.NS income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 44000000.00
BAYERCROP.NS balance_sheet (quarterly, 2025-09-30) — Inventory: 16607000000.00
BAYERCROP.NS balance_sheet (quarterly, 2025-09-30) — Invested Capital: 31235000000.00
BAYERCROP.NS balance_sheet (quarterly, 2025-09-30) — Investment Properties: 244000000.00
BAYERCROP.NS balance_sheet (quarterly, 2025-09-30) — Investmentin Financial Assets: 48000000.00
BAYERCROP.NS balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 567000000.00
BAYERCROP.NS balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 567000000.00
BAYERCROP.NS balance_sheet (quarterly, 2025-09-30) — Long Term Provisions: 936000000.00
BAYERCROP.NS income_statement (quarterly, 2025-09-30) — Net Income: 1527000000.00
BAYERCROP.NS income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 1527000000.00
BAYERCROP.NS income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 1527000000.00
BAYERCROP.NS income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 1527000000.00
BAYERCROP.NS income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 1527000000.00
BAYERCROP.NS income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 1527000000.00
BAYERCROP.NS income_statement (quarterly, 2025-09-30) — Net Interest Income: -44000000.00
BAYERCROP.NS income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -44000000.00
BAYERCROP.NS balance_sheet (quarterly, 2025-09-30) — Net PPE: 4211000000.00
BAYERCROP.NS balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 29756000000.00
BAYERCROP.NS balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Assets: 108000000.00
BAYERCROP.NS income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 2191000000.00
BAYERCROP.NS income_statement (quarterly, 2025-09-30) — Normalized Income: 1527000000.00
BAYERCROP.NS income_statement (quarterly, 2025-09-30) — Operating Income: 1909000000.00
BAYERCROP.NS income_statement (quarterly, 2025-09-30) — Operating Revenue: 15534000000.00
BAYERCROP.NS balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 44942092.00
BAYERCROP.NS balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 2563000000.00
BAYERCROP.NS balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 11428000000.00
BAYERCROP.NS balance_sheet (quarterly, 2025-09-30) — Other Equity Interest: 30786000000.00
BAYERCROP.NS balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 1479000000.00
BAYERCROP.NS balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 530000000.00
BAYERCROP.NS income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 138000000.00
BAYERCROP.NS income_statement (quarterly, 2025-09-30) — Other Operating Expenses: 2140000000.00
BAYERCROP.NS balance_sheet (quarterly, 2025-09-30) — Other Properties: 4123000000.00
BAYERCROP.NS balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 585000000.00
BAYERCROP.NS income_statement (quarterly, 2025-09-30) — Otherunder Preferred Stock Dividend: 0.00
BAYERCROP.NS balance_sheet (quarterly, 2025-09-30) — Payables: 5841000000.00
BAYERCROP.NS income_statement (quarterly, 2025-09-30) — Pretax Income: 2003000000.00
BAYERCROP.NS income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 10216000000.00
BAYERCROP.NS income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 144000000.00
BAYERCROP.NS balance_sheet (quarterly, 2025-09-30) — Share Issued: 44942092.00
BAYERCROP.NS balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 31235000000.00
BAYERCROP.NS balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 29756000000.00
BAYERCROP.NS income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
BAYERCROP.NS income_statement (quarterly, 2025-09-30) — Tax Provision: 476000000.00
BAYERCROP.NS income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.24
BAYERCROP.NS balance_sheet (quarterly, 2025-09-30) — Total Assets: 51910000000.00
BAYERCROP.NS balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 31235000000.00
BAYERCROP.NS balance_sheet (quarterly, 2025-09-30) — Total Debt: 1020000000.00
BAYERCROP.NS balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 31235000000.00
BAYERCROP.NS income_statement (quarterly, 2025-09-30) — Total Expenses: 13625000000.00
BAYERCROP.NS balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 20675000000.00
BAYERCROP.NS balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 7913000000.00
BAYERCROP.NS balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 1503000000.00
BAYERCROP.NS balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 410000000.00
BAYERCROP.NS balance_sheet (quarterly, 2025-09-30) — Working Capital: 24825000000.00
BAYERCROP.NS income_statement (quarterly, 2025-12-31) — +Operating Expense: 3754000000.00
BAYERCROP.NS income_statement (quarterly, 2025-12-31) — +Total Revenue: 11062000000.00
BAYERCROP.NS income_statement (quarterly, 2025-12-31) — Basic Average Shares: 44950681.00
BAYERCROP.NS income_statement (quarterly, 2025-12-31) — Basic EPS: 21.29
BAYERCROP.NS income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 6285000000.00
BAYERCROP.NS income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 148000000.00
BAYERCROP.NS income_statement (quarterly, 2025-12-31) — Depreciation Income Statement: 148000000.00
BAYERCROP.NS income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 44950681.00
BAYERCROP.NS income_statement (quarterly, 2025-12-31) — Diluted EPS: 21.29
BAYERCROP.NS income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 957000000.00
BAYERCROP.NS income_statement (quarterly, 2025-12-31) — EBIT: 1182000000.00
BAYERCROP.NS income_statement (quarterly, 2025-12-31) — EBITDA: 1330000000.00
BAYERCROP.NS income_statement (quarterly, 2025-12-31) — Gross Profit: 4777000000.00
BAYERCROP.NS income_statement (quarterly, 2025-12-31) — Interest Expense: 52000000.00
BAYERCROP.NS income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 52000000.00
BAYERCROP.NS income_statement (quarterly, 2025-12-31) — Net Income: 957000000.00
BAYERCROP.NS income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 957000000.00
BAYERCROP.NS income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 957000000.00
BAYERCROP.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 957000000.00
BAYERCROP.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 957000000.00
BAYERCROP.NS income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 957000000.00
BAYERCROP.NS income_statement (quarterly, 2025-12-31) — Net Interest Income: -52000000.00
BAYERCROP.NS income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -52000000.00
BAYERCROP.NS income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 1330000000.00
BAYERCROP.NS income_statement (quarterly, 2025-12-31) — Normalized Income: 957000000.00
BAYERCROP.NS income_statement (quarterly, 2025-12-31) — Operating Income: 1023000000.00
BAYERCROP.NS income_statement (quarterly, 2025-12-31) — Operating Revenue: 11062000000.00
BAYERCROP.NS income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 159000000.00
BAYERCROP.NS income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 2453000000.00
BAYERCROP.NS income_statement (quarterly, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
BAYERCROP.NS income_statement (quarterly, 2025-12-31) — Pretax Income: 1130000000.00
BAYERCROP.NS income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 6285000000.00
BAYERCROP.NS income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 148000000.00
BAYERCROP.NS income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
BAYERCROP.NS income_statement (quarterly, 2025-12-31) — Tax Provision: 173000000.00
BAYERCROP.NS income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.15
BAYERCROP.NS income_statement (quarterly, 2025-12-31) — Total Expenses: 10039000000.00
BAYERCROP.NS income_statement (annual, 2026-03-31) — +Operating Expense: 13023000000.00
BAYERCROP.NS income_statement (quarterly, 2026-03-31) — +Operating Expense: 3786000000.00
BAYERCROP.NS income_statement (annual, 2026-03-31) — +Total Revenue: 54980000000.00